e12513#Background:The Breast Cancer Index (BCI) is a gene expression-based biomarker that reports two results: BCI Predictive [BCI (H/I)], which predicts benefit from extended endocrine therapy (EET), and BCI Prognostic, which combines the Molecular Grade Index (MGI) with BCI (H/I) to ...
NP: Normal persons; BCP: Breast cancer patients CONCLUSIONS This study investigates discriminating tongue features to distinguish between BCPs and normal people, and establishes differentiating index to facilitate the non-invasive detection of BC. The Mann–Whitney test showed that the amount of tongue...
Breast Cancer Recurrence, Early Stage 1, 2 Breast Cancer Test, Prognostic Test For Breast Cancer In India, Tumour Test, Screening Test, Oncotype dx Test in India, CanAssistBreast, Oncostem, India
Bartlett J, Mallon E, Cooke T (2003) The clinical evaluation of HER-2 status: which test to use? J Pathol 199: 411–417 Article CAS Google Scholar Chia S, Norris B, Speers C, Cheang M, Gilks B, Gown AM, Huntsman D, Olivotto IA, Nielsen TO, Gelmon K (2008) Human epidermal ...
These data might help oncologists and patients to choose the most appropriate test when considering chemotherapy use and/or extended endocrine therapy. Trial Registration isrctn.com Identifier: ISRCTN18233230 Introduction Almost all women with estrogen receptor (ER)–positive primary breast cancer are ...
英語化学名:CA 15-3 (Breast Cancer Marker Test) 化学名:CA 15-3 (Breast Cancer Marker Test) 别名: CA 15-3 (Breast Cancer Marker Test) CAS番号: 分子式: 分子量:0 EINECS: Mol File:Mol File Browse by Nationality Suppliers JAPAN suppliers China (1) All (1) Eninquiry Recommend You ...
(n = 3), *p-value ≤ 0.05 using one-way ANOVA and Bonferroni post hoc test.dIgf-2mRNA expression levels were quantified in tumor cells, non-immune stromal cells and tumor-associated macrophages isolated from murine breast cancer tumors by flow cytometry. Error bars represent s.e. ...
"Oncotype DX" (ODX) is a genomic test used to quantify the likelihood of distant recurrence (Recurrence Score i.e. RS) and predict chemotherapy benefit... V Deshmane,A Raniwala - 《Cancer Research》 被引量: 0发表: 2021年 Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the ...
breast-cancer-train.csv (0)踩踩(0) 所需:1积分 SdCardFailureException.md 2025-01-06 22:26:56 积分:1 SimCardFailureException.md 2025-01-06 22:25:54 积分:1 AudioRecordingException.md 2025-01-06 22:24:32 积分:1 CameraFailureException.md ...
Although OncotypeDx is the only gene expression-based test with prospectively] validated clinical utility for prediction of chemotherapy benefit (level I evidence), many other validated prognostic tests exist, including Mammaprint, Prosigna, Breast Cancer Index, Endopredict, and Genomic Grade Index. These...